VuCOMP Gets FDA Approval for Mammo CAD System
Computer-aided detection system developer VuCOMP Inc. has received FDA premarket approval for its film mammography CAD software.
Computer-aided detection system developer VuCOMP Inc. has received FDA premarket approval for its film mammography CAD software. This is the first new mammography CAD system approved by the FDA since 2007, the company said.
M-Vu is indicated for use in screening mammography to identify areas consistent with breast cancer for radiologist review after completing an initial read, according to the company.
In a reader study at the University of North Carolina at Chapel Hill, physicians using the M-Vu CAD system were more effective at reading mammograms and demonstrated a significant increase in the ability to discriminate between cancer and noncancer, according to VuCOMP.
The company will be providing a digital version of the system in the “near future,” VuCOMP president and CEO Jeff Wehnes said in a statement.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
